Just over a year ago, the Trump Administration issued an executive order meant to accelerate the development of nuclear power in the US. While an entire startup ecosystem has developed around the use ...
Shell's CEO used a specific phrase on the earnings call that captures how serious the global oil supply situation has become. The shortage Sawan described has an unusual characteristic that means it ...
Shell said it has agreed to buy Canada’s ARC Resources in a deal valued at $16.4 billion. The transaction is expected to boost Shell’s long-term oil and gas production. ARC Resources is a company ...
Mr. Shell, the former chief executive of NBCUniversal, is leaving after becoming entangled in a legal battle with a professional gambler, R.J. Cipriani. By Benjamin Mullin and Lauren Hirsch Jeff Shell ...
An AI-identified lipid called P1 delivered mRNA 14.8 times more efficiently than the clinically approved lipid ALC-0315. Lipid P1's unique three-dimensional conformation allows it to bind ...
This walking tour explores a modern opera house in Zhuhai, China, known for its large shell shaped structure. The building features curved glass panels and a bold architectural form that stands out ...
Competition in the world of business is a good thing for the consumer, right? It keeps prices down and forces innovation. Well, the motor oil space isn't as competitive as you might have thought. For ...
A central piece of a closed crude oil refinery in Convent recently came crashing down as Shell Oil shifts the nearly 60-year-old complex toward making renewable fuels, company officials confirmed. The ...
Plasmonic metal nanostructures (e.g., Au, Cu, Pt, Ru) have attracted considerable attention in photothermal catalysis due to their unique capabilities in light-field regulation and energy conversion.
Abstract: Nanoscale interconnect materials enable high-power devices to efficiently dissipate heat and serve at high temperatures. AgCu nanoparticles with core-shell structure(Ag shell covering Cu ...
Interest in lipid nanoparticles (LNPs) as delivery vehicles for precision therapies in genetic diseases and cancers remains at an all-time high. Now, scientists from the University of Pennsylvania, ...